Lunai Bioworks (RENB) Institutional Ownership $0.13 -0.01 (-6.12%) As of 12:31 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lunai Bioworks (NASDAQ:RENB)CurrentInstitutional OwnershipPercentage71.41%Number ofInstitutional Buyers(last 12 months)24TotalInstitutional Inflows(last 12 months)$2.74MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$675.96K Get RENB Insider Trade Alerts Want to know when executives and insiders are buying or selling Lunai Bioworks stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data RENB Institutional Buying and Selling by Quarter Lunai Bioworks Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2025 Jane Street Group LLC893,046$258K0.0%N/A0.519% 8/14/2025 Qube Research & Technologies Ltd228,885$66K0.0%N/A0.133% 8/13/2025 Marshall Wace LLP309,350$90K0.0%N/A0.180% 8/8/2025 Geode Capital Management LLC1,015,917$294K0.0%-57.1%0.590% 6/27/2025 Goldman Sachs Group Inc.182,054$99K0.0%-50.1%0.106% 5/16/2025Goldman Sachs Group Inc.182,054$99K0.0%-50.1%0.115% 5/12/2025Nuveen LLC151,681$82K0.0%N/A0.096% 2/17/2025ProShare Advisors LLC32,570$27K0.0%N/A0.021% 2/17/2025Nuveen Asset Management LLC151,681$127K0.0%+128.8%0.096% 2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.64,923$54K0.0%+174.8%0.041% Get the Latest News and Ratings for RENB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lunai Bioworks and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025Deutsche Bank AG127,437$107K0.0%N/A0.080% 2/17/2025Cantor Fitzgerald L. P.300,000$251K0.0%+200.0%0.189% 2/14/2025Northern Trust Corp889,357$743K0.0%+49.5%0.560% 2/14/2025The Manufacturers Life Insurance Company45,797$38K0.0%N/A0.029% 2/14/2025Voya Investment Management LLC35,312$30K0.0%N/A0.022% 2/14/2025Price T Rowe Associates Inc. MD45,198$38K0.0%+183.5%0.028% 2/14/2025MetLife Investment Management LLC75,454$63K0.0%N/A0.048% 2/13/2025Barclays PLC179,844$150K0.0%+158.7%0.113% 2/13/2025Wells Fargo & Company MN59,101$49K0.0%+224.9%0.037% 2/12/2025Geode Capital Management LLC2,332,634$1.95M0.0%+48.4%1.470% 2/12/2025JPMorgan Chase & Co.353,833$296K0.0%+280.4%0.223% 2/11/2025Corebridge Financial Inc.57,495$48K0.0%+114.8%0.036% 2/6/2025Charles Schwab Investment Management Inc.362,126$303K0.0%+82.0%0.228% 2/4/2025Bank of New York Mellon Corp223,915$187K0.0%+137.2%0.141% 1/31/2025New York State Common Retirement Fund52,500$44K0.0%-21.3%0.033% 1/30/2025Rhumbline Advisers112,960$94K0.0%+122.6%0.071% 1/17/2025SG Americas Securities LLC51,725$43K0.0%+193.3%0.033% 12/26/2024JPMorgan Chase & Co.93,010$45K0.0%+347.6%0.059% 11/19/2024Barclays PLC69,531$34K0.0%+315.7%0.044% 11/16/2024Geode Capital Management LLC1,572,290$760K0.0%-9.0%0.972% 11/15/2024Barclays PLC69,531$34K0.0%+315.7%0.043% 11/15/2024State Street Corp1,323,832$640K0.0%+3.8%0.819% 8/1/2024Rhumbline Advisers45,197$79K0.0%N/A0.031% 7/26/2024Bank of New York Mellon Corp125,461$220K0.0%N/A0.085% 5/17/2024Tidal Investments LLC36,972$98K0.0%N/A0.026% 5/10/2024Vanguard Group Inc.3,916,672$10.38M0.0%+904.0%2.726% 5/7/2024SG Americas Securities LLC17,263$46K0.0%N/A0.012% (Data available from 1/1/2016 forward) RENB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RENB shares? During the previous two years, 28 institutional investors and hedge funds held shares of Lunai Bioworks. The most heavily invested institutionals were Vanguard Group Inc. ($10.38M), Northern Trust Corp ($743K), State Street Corp ($640K), Charles Schwab Investment Management Inc. ($303K), JPMorgan Chase & Co. ($296K), Geode Capital Management LLC ($294K), and Jane Street Group LLC ($258K).Learn more on Lunai Bioworks' institutional investors. What percentage of Lunai Bioworks' stock is owned by institutional investors? 71.41% of Lunai Bioworks' stock is owned by institutional investors. Learn more on RENB's institutional investor holdings. Which institutional investors have been buying Lunai Bioworks' stock? Of the 26 institutional investors that purchased Lunai Bioworks' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vanguard Group Inc. ($3.53M), Jane Street Group LLC ($893.05K), Geode Capital Management LLC ($760.34K), JPMorgan Chase & Co. ($333.05K), Marshall Wace LLP ($309.35K), Northern Trust Corp ($294.47K), and Bank of New York Mellon Corp ($254.99K). How much institutional buying is happening at Lunai Bioworks? Institutional investors have bought a total of 4,367,996 shares in the last 24 months. This purchase volume represents approximately $2.74M in transactions. Which of Lunai Bioworks' major shareholders have been selling company stock? The following institutional investors have sold Lunai Bioworks stock in the last 24 months: Geode Capital Management LLC ($1.51M), Goldman Sachs Group Inc. ($364.85K), and New York State Common Retirement Fund ($14.20K). How much institutional selling is happening at Lunai Bioworks? Institutional investors have sold a total of 1,886,786 shares in the last 24 months. This volume of shares sold represents approximately $675.96K in transactions. Related Companies Biomea Fusion Major Shareholders Compugen Major Shareholders Protara Therapeutics Major Shareholders Anixa Biosciences Major Shareholders Fate Therapeutics Major Shareholders aTyr Pharma Major Shareholders Spero Therapeutics Major Shareholders HilleVax Major Shareholders Atossa Genetics Major Shareholders MEI Pharma Major Shareholders This page (NASDAQ:RENB) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lunai Bioworks Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lunai Bioworks With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.